Rossi Andrea, Perrella Lara, Scotti Stefano, Olmastroni Elena, Galimberti Federica, Ardoino Ilaria, Orlando Valentina, Menditto Enrica, Franchi Carlotta, Casula Manuela
Epidemiology and Preventive Pharmacology Service (SEFAP), Department of Pharmacological and Biomolecular Sciences (DiSFeB), University of Milan, 20133 Milan, Italy.
IRCCS MultiMedica, 20099 Sesto San Giovanni, Italy.
J Clin Med. 2024 Oct 21;13(20):6283. doi: 10.3390/jcm13206283.
: Proton pump inhibitors (PPIs) are some of the most frequently prescribed medications, but they are often used inappropriately, either being prescribed without a clear indication or continued for longer than necessary. In such cases, deprescribing is recommended. However, despite its proven effectiveness, the implementation of deprescribing in clinical practice remains inconsistent and varied, making it challenging to identify the most effective strategies. The goal is to provide a comprehensive outline of deprescribing interventions for PPI therapy implemented across various settings and by different healthcare professionals. : The study is designed to be a systematic review of the published literature. PubMed, Embase, and Web of Science databases were searched from 1 January 1989 (the first PPI on the market) to 30 September 2024 for articles assessing PPI deprescribing in adult patients, focusing on the implementation rate (primary outcome) or effects on symptoms (secondary outcome). : After screening, 66 studies were included, predominantly pragmatic trials (N = 32) or randomized controlled trials (N = 25). We found a variety of interventions promoting PPI deprescription. Collaborative efforts involving multiple healthcare professionals, the use of algorithms for clinical decision-making, and patient involvement have proven to be key elements in the most effective strategies. Discontinuing therapy may not be advisable in cases of recurrent symptoms, suggesting that on-demand therapy could be a recommended approach. Deprescribing is particularly relevant for individuals with mild illnesses and symptoms, where tapering can effectively mitigate the rebound symptoms often associated with abrupt discontinuation. : Given the current prevalence of inappropriate PPI prescribing, it is imperative to raise awareness among both physicians and patients about the importance of the deprescribing process, which should be tailored to the specific needs of each patient, considering his/her medical history, current health status, and personal preferences.
质子泵抑制剂(PPIs)是最常被处方的药物之一,但它们经常被不恰当地使用,要么在没有明确指征的情况下被处方,要么持续使用的时间超过必要时长。在这种情况下,建议减药。然而,尽管减药已被证明有效,但在临床实践中其实施仍然不一致且存在差异,这使得确定最有效的策略具有挑战性。目标是全面概述在各种环境中由不同医疗保健专业人员实施的PPIs治疗减药干预措施。
该研究旨在对已发表的文献进行系统综述。从1989年1月1日(市场上第一种PPI)至2024年9月30日,在PubMed、Embase和科学网数据库中搜索评估成年患者PPIs减药情况的文章,重点关注实施率(主要结局)或对症状的影响(次要结局)。
筛选后,纳入了66项研究,主要是实用试验(N = 32)或随机对照试验(N = 25)。我们发现了多种促进PPIs减药的干预措施。涉及多名医疗保健专业人员的协作努力、临床决策算法的使用以及患者的参与已被证明是最有效策略的关键要素。在症状复发的情况下,停止治疗可能不可取,这表明按需治疗可能是一种推荐的方法。减药对于患有轻度疾病和症状的个体尤为重要,在这种情况下逐渐减量可以有效减轻通常与突然停药相关的反跳症状。
鉴于目前PPIs处方不当的普遍情况,必须提高医生和患者对减药过程重要性的认识,减药过程应根据每个患者的具体需求进行调整,考虑其病史、当前健康状况和个人偏好。